Verano Holdings (VRNO) Revenue (2021 - 2026)
Verano Holdings' (VRNO) quarterly Revenue came in at $208.2 million in Q1 2026, down 0.78% year-on-year from $209.8 million in Q1 2025, and up 0.76% on a QoQ basis from $206.6 million in Q4 2025.
Verano Holdings (VRNO) Revenue (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Revenue data on file, last reported at $208.2 million in Q1 2026.
- On a quarterly basis, Revenue fell 0.78% year-over-year to $208.2 million in Q1 2026; TTM through Mar 2026 was $819.9 million, a 5.45% decrease from a year earlier, with the FY2025 full-year figure at $821.5 million, down 6.5% from the prior year.
- Revenue for Q1 2026 stood at $208.2 million, up from $206.6 million in the prior quarter.
- Over the last five years, Revenue for VRNO reached as high as $240.1 million in Q3 2023 and fell as low as $854000.0 in Q1 2024.
- Historically, Revenue has averaged $206.2 million across 5 years, with a median of $218.2 million in 2024.
- Across the five-year window, Revenue sank 99.62% in 2024 and jumped 24467.8% in 2025, its largest moves.
- Year by year, Revenue stood at $225.9 million in 2022, then rose by 4.98% to $237.2 million in 2023, then decreased by 8.0% to $218.2 million in 2024, then fell by 5.31% to $206.6 million in 2025, then gained by 0.76% to $208.2 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $208.2 million in Q1 2026, $206.6 million in Q4 2025, and $202.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 781.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 208.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 208.18 Mn |
| Dec 31, 2025 | 206.61 Mn |
| Sep 30, 2025 | 202.81 Mn |
| Jun 30, 2025 | 202.27 Mn |
| Mar 31, 2025 | 209.81 Mn |
| Dec 31, 2024 | 218.21 Mn |
| Sep 30, 2024 | 216.68 Mn |
| Jun 30, 2024 | 222.39 Mn |
| Mar 31, 2024 | 854,000.00 |
| Dec 31, 2023 | 237.19 Mn |
| Sep 30, 2023 | 240.09 Mn |
| Jun 30, 2023 | 234.12 Mn |
| Mar 31, 2023 | 227.06 Mn |
| Dec 31, 2022 | 225.93 Mn |
| Sep 30, 2022 | 227.59 Mn |
| Jun 30, 2022 | 223.66 Mn |
| Mar 31, 2022 | 202.24 Mn |
| Dec 31, 2021 | 211.42 Mn |
| Sep 30, 2021 | 206.47 Mn |
| Jun 30, 2021 | 199.07 Mn |